Cytokine Expression in Labial Salivary Glands from Patients with Primary Sjöugren's Syndrome

References

• Fox R. I., Howell F. V., Bone R. C., Michelson P. Primary Sjögren's syndrome: clinical and immunopathological features. Sem Arth Rheum 1984; 14: 77–103
   PubMed Web of Science ®Google Scholar
• Jacobsson L. T. H., Axell T. E., Hansen B. U., Henricsson V. J., Larsson Lieberkind K., et al. Dry eyes or mouth-an epidemiological study in Swedish adults, with special reference to primary Sjögren's syndrome. J Autoimmun 1989; 2: 521–527
   PubMed Web of Science ®Google Scholar
• Strand V., Talal N. Advances in the diagnosis and concept of Sjögren's syndrome (autoimmune exocrinopathy). Bull Rheum Dis 1980; 30: 1046–1052
   Google Scholar
• Talal N. Recent developments in the immunology of Sjögren's syndrome (autoimmune exocrinopathy). Scand J Rheumatol 1986, suppl 61: 76–82
   Google Scholar
• Enk C., Oxholm P. Decreased interleukin-1 responsiveness of blood lymphocytes in patients with primary Sjögren's syndrome. Clin Exp Immunol 1988; 6: 67–69
   Google Scholar
• Enk C., Oxholm P., Tvede N., Bendtzen K. Blood mononuclear cells in patients with primary Sjögren's syndrome: production of interleukins, enumeration of interleukin-2 receptors, and DNA synthesis. Scand J Rheumatol 1986, suppl 61: 131–134
   Google Scholar
• Miyasaka N., Murota N., Yamaoka K., Sato K., Yamada T., Nishido T., et al. Interleukin 2 defect in the peripheral blood and the lung in patients with Sjögren's syndrome. Clin Exp Immunol 1986; 65: 497–505
   PubMed Web of Science ®Google Scholar
• Miyasaka N., Yamada T., Sato K., Murata H., Nishido T., Yata J., et al. Decreased IL-2 production by peripheral blood lymphocytes in patients with Sjögren's syndrome. An analysis of defective mechanisms. Jap J Rheumatol 1986; 1: 31–39
   Google Scholar
• Pedersen B. K., Oxholm P., Manthorpe R., Andersen V. Interleukin 2 augmentation of the defective natural killer cell activity in patients with primary Sjögren's syndrome. Clin Exp Immunol 1986; 63: 1–7
   PubMed Web of Science ®Google Scholar
• Takeda A., Minato N., Kano S. Selective impairment of a-inter-feron-mediated natural killer augmentation in Sjögren's syndrome: differential effects of α-interferon, m`-interferon, and interleukin-2 on cytolytic activity. Clin Exp Immunol 1987; 70: 354–363
   PubMed Web of Science ®Google Scholar
• Fox R. I., Theofilopoulos A. N., Altman A. Production of interleukin 2 (IL 2) by salivary gland lymphocytes in Sjögren's sydnrome. Detection of reactive cells by using antibody directed to synthetic peptides of IL 2. J Immunol 1985; 135: 3109–3115
   PubMed Web of Science ®Google Scholar
• Dalavanga Y. A., Drosos A. A., Moutsopoulos H. M. Labial salivary gland immunopathology in Sjögren's syndrome. Scand J Rheumatol 1986, suppl 61: 67–70
   Google Scholar
• Yamoaka K., Miyasaka N., Sato K., Okuda M., Nishioka K. B cell hyperresponsiveness in Sjögren's syndrome. Autoimmunity 1989; 3: 261–269
   PubMed Web of Science ®Google Scholar
• Shiozawa S., Shiozawa K., Shimizu S., Tanaka Y., Morimoto I., Yoshihara R., et al. Immunoreactive circulating alpha-interferon is low in Sjögren's syndrome. Br J Rheumatol 1990; 29: 50–52
   PubMedGoogle Scholar
• Rowe D., Griffiths M., Stewart J., Novick D., Beverley P. C. L., Isenberg D. A. HLA class I and II, interferon, interleukin 2, and the interleukin 2 receptor expression on labial biopsy specimens from patients with Sjögren's syndrome. Ann Rheum Dis 1987; 46: 580–586
   PubMed Web of Science ®Google Scholar
• Hooks J. J., Moutsopoulos H. M., Geis S. A., Stahl N. I., Decker J. L., Notkins A. L. Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med 1979; 301: 5–8
   PubMed Web of Science ®Google Scholar
• Bendtzen K. Immune hormones (cytokines); pathogenetic role in autoimmune rheumatic and endocrine diseases. Autoimmun 1989; 2: 177–189
   PubMed Web of Science ®Google Scholar
• Schultzberg M., Svenson S. B., Unden A., Bartfai T. Interleukin-1-like immunoreactivity in peripheral tissues. J Neurosci Res 1987; 18: 184–189
   PubMed Web of Science ®Google Scholar
• Oxholm A., Oxholm P., Staberg B., Bendtzen K. Immunohisto-logical detection of interleukin-1-like molecule(s) and tumour necrosis factor in human epidermis before and after UVB-irradiation in vivo. Br J Dermatol 1988; 118: 369–376
   PubMed Web of Science ®Google Scholar
• Oxholm A., Oxholm P., Staberg B., Bendtzen K. Interleukin-6 in the epidermis of patients with psoriasis before and during PUVA treatment. Acta Dermato-Venereol 1989; 69: 195–199
   PubMed Web of Science ®Google Scholar
• Oxholm A., Oxholm P., Permin H., Bendtzen K. Epidermal tumour necrosis factor and interleukin 6-like activities in AlDS-related Kaposi's sarcoma. An immunohistological study. APMIS 1989; 97: 533–538
   PubMed Web of Science ®Google Scholar
• Oxholm A., Oxholm P., Staberg B., Bendtzen K. Expression of inlerleukin-6-like molecules and tumour necrosis factor after topical treatment of psoriasis with a new vitamin D analogue (MC 903). Acta Dermato-Venereol 1989; 69: 385–390
   PubMed Web of Science ®Google Scholar
• Tabibzadeh S. S., Poubouridis D., May L. T., Sehgal P. B. Inter-leukin-6 immunoreactivity in human tumors. Am J Pathol 1989; 135: 427–433
   PubMed Web of Science ®Google Scholar
• McCall J. L., Yun K., Funamoto S., Parry B. R. In vivo immuno-hislochemical identification of tumor necrosis factor/cachectin in human lymphoid tissue. Am J Pathol 1989; 135: 421–425
   PubMed Web of Science ®Google Scholar
• Ruco L. P., Stoppacciaro A., Pomponi D., Boraschi D., Santoni A., Tagliabue A., et al. Immunoreactivity for IL-lβ and TNFα in human lymphoid and nonlymphoid tissues. Am J Pathol 1989; 135: 889–897
   PubMed Web of Science ®Google Scholar
• Daniels T. E., Talal N. Diagnosis and differential diagnosis of Sjögren's syndrome. Sjögren's Syndrome. Clinical and Immunological Aspects, N. Talal, H. M. Moutsopoulos, S. S. Kassan. Springer-Verlag, Berlin, Heidelberg, New York, London, Paris, Tokyo 1987; 193–199
   Google Scholar
• Daniels T. E. Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 1984; 27: 147–156
   PubMed Web of Science ®Google Scholar
• Harboe N. M. G., Ingild A. Immunization, isolation of immunoglobulins and antibody titre determination. Scand J Immunol 1983; 17: 345–351, suppl
   PubMedGoogle Scholar
• Oxholm A., Diamant M., Oxholm P., Bendtzen K. Interleukin-6 and tumour necrosis factor a are expressed on keratinocytes but not on Langerhans cells. APMIS 1991; 99: 58–64
   PubMed Web of Science ®Google Scholar
• Freemont A. J., Jones C. JP. Endothelial specialization of salivary gland vessels for accelerated lymphocyte transfer in Sjögren's syndrome. J Rheumatol 1983; 10: 801–804
   PubMed Web of Science ®Google Scholar
• Oxholm P., Daniels T. E. Peripheral nerve proliferation in labial salivary glands of patients with primary Sjögren's syndrome, SubmittEd
   Google Scholar
• Youinou P., Pennec Y. Immunopathological features of primary Sjögren's sydnrome. Clin Exp Rheumatol 1987; 5: 173–184
   PubMed Web of Science ®Google Scholar